Evidence map›Paper›PMID 30470963›Full record

ArticleJournal of industrial microbiology & biotechnology2019

Multiple-step chromosomal integration of divided segments from a large DNA fragment via CRISPR/Cas9 in Escherichia coli.

Yanjun Li, Fangqing Yan, Heyun Wu, Guoliang Li, Yakun Han, Qian Ma, Xiaoguang Fan, Chenglin Zhang, Qingyang Xu, Xixian Xie and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Biosynthesis of poly(3-hydroxybutyrate-Biodesign research · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development and Application of CRISPR/Cas in Microbial Biotechnology.Frontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yanjun LiCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Fangqing YanCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Heyun WuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Guoliang LiCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Yakun HanCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Qian MaCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Xiaoguang FanCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Chenglin ZhangCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Qingyang XuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Xixian XieCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China. xixianxie@tust.edu.cn.
Ning ChenCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China. ningch@tust.edu.cn.
Tianjin University of Science and Technology · CN

Funding

China Postdoctoral Science Foundation funded project 2016M601269China Postdoctoral Science Foundation funded project 2017M61170National High Technology Research and Development Program 2015AA021003National Natural Science Foundation of China 31500026National Natural Science Foundation of China 31700037Tianjin Key Technology R & D program of Tianjin Municipal Science and Technology Commission 17YFZCSY01050
6 · The paper itself

Abstract

Although CRISPR/Cas9-mediated gene editing technology has developed vastly in Escherichia coli, the chromosomal integration of large DNA fragment is still challenging compared with gene deletion and small fragment integration. Moreover, to guarantee sufficient Cas9-induced double-strand breaks, it is usually necessary to design several gRNAs to select the appropriate one. Accordingly, we established a practical daily routine in the laboratory work, involving multiple-step chromosomal integration of the divided segments from a large DNA fragment. First, we introduced and optimized the protospacers from Streptococcus pyogenes in E. coli W3110. Next, the appropriate fragment size for each round of integration was optimized to be within 3-4 kb. Taking advantage of the optimized protospacer/gRNA pairs, a DNA fragment with a total size of 15.4 kb, containing several key genes for uridine biosynthesis, was integrated into W3110 chromosome, which produced 5.6 g/L uridine in shake flask fermentation. Using this strategy, DNA fragments of virtually any length can be integrated into a suitable genomic site, and two gRNAs can be alternatively used, avoiding the tedious construction of gRNA-expressing plasmids. This study thus presents a useful strategy for large DNA fragment integration into the E. coli chromosome, which can be easily adapted for use in other bacteria.

Indexed as

CRISPR-Cas SystemsDNA FragmentationBase SequenceChromosomes, BacterialCloning, MolecularDNA, BacterialEscherichia coliGene DeletionGene EditingGenes, BacterialPlasmidsRNA, Guide, CRISPR-Cas SystemsStreptococcus pyogenesDNA, BacterialRNA, Guide, CRISPR-Cas SystemsChromosomal integrationCRISPR/Cas9Escherichia coliLarge DNA fragmentProtospacer

Identifiers

PMID30470963
OpenAlexW2901028097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.